Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

2 drugs in development

Preclinical2

By Therapeutic Area

top 1

Cardiovascular

150%

R&D Momentum

58/100

Pipeline Velocity

30/100

Trial Completion Rate

69/100

Pipeline Concentration

50/100

Pipeline Freshness

20/100

Strategic Signals

↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 3, 2026

Recruiting

Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy

Nov 3, 2026

Recruiting

Identification of Biomarkers for Vagus Nerve Stimulation in Patients With Refractory Epilepsy

Earlier

Oct 21, 2026TrialSurgical Margin Assessment Using Intra-operative High-resolution PET/CT in Patients With Cancers Referred to Surgical Resection, an Exploratory Pilot Study

Oct 21, 2026TrialTemporal Dynamics of Peripheral SpO₂ During Reoxygenation

Sep 29, 2026TrialMulticentre Evaluation of Spinal Bone Pathologies Using Zero Echo Time (ZTE) Pseudo-CT MRI Sequences: a Clinical Implementation Study

Sep 26, 2026TrialIdentification of Urinary Retention by Simplified Ultrasound: Diagnostic Without Volumetric Measurements

Sep 22, 2026TrialEvaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH

Sep 22, 2026TrialBELux Children OutcoME During A(@)Dulthood With Growth Hormone Deficiency

4 more events

Jul 24, 2026TrialEffect of Continuous Nebulisation of Isotonic Saline Solution Combined With Heated Humidification on Mucociliary Clearance in Healthy Subjects

Jul 24, 2026TrialImpact of Continuous Isotonic Saline Nebulisation Combined With Heated Humidification on the Rheology of Bronchial Secretions.

Jul 15, 2026TrialTargeting Myosteatosis Though Physical Exercise to Treat Metabolic Dysfunction-associated Steatotic Liver Disease

Jul 15, 2026TrialMyokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

biomarkerPreclinical

Unknown / Other

Immunotherapy

Molecular TargetPreclinical

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)